echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Academician on H7N9 prevention and control: China's independent development of vaccines or may market

    Academician on H7N9 prevention and control: China's independent development of vaccines or may market

    • Last Update: 2020-06-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Business Agency March 10 thin spring is the season of high incidence of infectious diseasesLi Lanxuan, a member of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), an expert in infectious diseases and a member of the Chinese Academy of Engineering, said in an exclusive interview with Xinhua News Agency in Beijing on July 7 that closing the live poultry market and implementing targeted slaughter is the most effective measure for the prevention and control of H7N9 at the source;" From the current situation, human infection with H7N9 avian influenza epidemic characteristics have not changed significantly, cases are still mainly distributed, there is no obvious transmission between peopleLi said that human-to-human transmission is confined to the family, and the probability is very lowstudies have found that the H7N9 virus originates from poultry"The live poultry market is the source of H7N9 avian influenzaLi lanxuan pointed out that closing the live poultry market and implementing targeted slaughter are the most effective measures for source prevention and control" can control large-scale transmission as long as it controls birdsLi said the closure of the live poultry market is crucial to reducing infectionLi Lanxuan, a, said that China's self-developed H7N9 avian influenza virus vaccine has been successfully developed, through technical verification, and throughenterprisesthe production of vaccine strains" is currently submitted to The ChinaPharmaceuticalThe Biological Products Inspection And Verification, waiting for the approval of the State Food and Drug Administration can enter the first and second phase of clinical trials Li Lanxuan said, fast, should be a month or two later can be listed, use In October 2013, the first hospital affiliated with Zhejiang University Medical College, led by Li Lanxuan, joint lying units, successfully developed the H7N9 avian influenza virus vaccine strain, breaking the history of China's influenza vaccine strain provided by foreign countries for the first time she said there was no need for the public to be vaccinated blindly, but that high-risk, susceptible people who were exposed to poultry were able to be vaccinated In 2003, the SARS outbreak ravaged China Ten years later, H7N9 attacked the nation again Who's worse off with the two? What is the difference between prevention and treatment methods? Li Lanxuan said that when SARS is prevalent, people are the source of infection and should be brought under control as soon as possible "Because it wasn't found in the early days, it spread "
    " H7N9 was found early, the source of infection is poultry, easy to control But there are so many birds in China that there needs to be more monitoring in the future, she said H7N9, H10N8, H5N1 and other human infections of avian influenza are closely related to live poultry market transactions Li Lanxuan, , said that there are few small-scale farmers in advanced developed countries to raise chickens into the market and circulation "China's poultry industry should also be large-scale, intensive breeding-oriented, upgrading industry, scientific prevention and control of human infection with avian influenza."
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.